Probiotics in neonatal intensive care - Back to the future

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 55, Issue 3, 2015, Pages 210-217

  Deshpande, Girish ^a,b   Rao, Shripada ^c,d   Patole, Sanjay ^d,e  

^a NEPEAN HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e KING EDWARD MEMORIAL HOSPITAL   (Australia)

Author keywords

Enterocolitis; Intensive care; Necrotising; Newborn; Probiotics; Review

Indexed keywords

PROBIOTIC AGENT;

CLINICAL PROTOCOL; CLINICAL STUDY; CRITICAL ILLNESS; DIET SUPPLEMENTATION; DRUG APPROVAL; DRUG SAFETY; GASTROINTESTINAL MOTILITY; HUMAN; IMMUNOMODULATION; INTENSIVE CARE UNIT; INTESTINAL DYSMOTILITY; INTESTINE; INTESTINE FLORA; INTESTINE FUNCTION; META ANALYSIS (TOPIC); MICROBIAL COLONIZATION; MORBIDITY; NECROTIZING ENTEROCOLITIS; NEWBORN CARE; NEWBORN INTENSIVE CARE; PARENTERAL NUTRITION; PRACTICE GUIDELINE; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW (TOPIC); DRUG EFFECTS; GASTROINTESTINAL TRACT; MICROBIOLOGY; NEWBORN; PHYSIOLOGY; PROCEDURES;

GASTROINTESTINAL TRACT; HUMANS; IMMUNOMODULATION; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; PRACTICE GUIDELINES AS TOPIC; PROBIOTICS;

EID: 84937022576     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/ajo.12328     Document Type: Review

References (98)

1. Ofek Shlomai N, Deshpande G, Rao S, Patole S. Probiotics for preterm neonates: what will it take to change clinical practice? Neonatology 2014; 105: 64-70.
2. Food and Agriculture Organization of the United Nations (FAO). Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food: London, Ontario, Canada, April 30 and May 1, 2002.
3. Sir Thomas Edward Thorpe. A dictionary of applied chemistry, Vol. 3. London: Longmans, Green and Co, 1922; 159.
4. Anukam KC, Reid G. Probiotics: 100 years (1907-2007) after Elie Metchnikoff's Observation Communicating Current Research and Educational Topics and Trends in Applied Microbiology (Méndez-Vilas A. ed.) 2007;466-473.
5. Metchnikoff E. Études sur la flore intestinale. Ann Inst Pasteur (Paris) 1908; 22: 929-955.
6. Renneberg R. Beer, bread, and cheese-the tasty side of biotechnology. In: Demain A, ed. Biotechnology for Beginners, 1st edn. London: Elsevier, 2007; 25.
7. Tissier H. 1900. Recherches sur la flore intestinale des nourrissons (etat normal et pathologique) Paris Théses, 1-253.
8. Shirota M, Aso K, Iwabuchi A. Study on microflora of human intestine I. Alteration of the constitution of intestinal flora by oral administration of L. acidophilus strain Shirota to healthy infants. Jpn J Bacteriol 1966; 21: 274-283.
9. Lilly DM, Stillwell RH. Probiotics: growth promoting factors produced by microorganisms. Science 1965; 147: 747.
10. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet 2006; 368: 1271-1283.
11. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986; 33: 179-201.
12. Wales PW, Christison-Lagay ER. Short bowel syndrome: epidemiology and etiology. Semin Pediatr Surg 2010; 19: 3-9.
13. Guarino SG. Neonatal onset intestinal failure: an Italian multicenter study. J Pediatr 2008; 153: e674-e676.
14. Hsueh W, Caplan MS, Qu XW et al. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol 2003; 6(1): 6-23.
15. Leaphart CL, Cavallo J, Gribar SC et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol 2007; 179: 4808-4820.
16. Claud EC, Walker WA. Bacterial colonization, probiotics, and necrotizing enterocolitis. J Clin Gastroenterol 2008; 42: S46-S52.
17. Patole S. Prevention and treatment of necrotising enterocolitis in preterm neonates. Early Hum Dev 2007; 83: 635-642.
18. Martin CR, Walker WA. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin Perinatol 2008; 32: 127-137.
19. Claude EC, Walker WA. Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. FASEB J 2001; 15: 1398-1403.
20. Wang Y, Hoenig JD, Malin KJ. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J 2009; 3: 944-954.
21. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 2004; 28: 405-440.
22. Lawton EM, Ross RP, Hill C et al. Two-peptide lantibiotics: a medical perspective. Mini Rev Med Chem 2007; 7: 1236-1247.
23. Underwood MA, German JB, Lebrilla CB, Mills DA. Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut. Pediatr Res 2015; 77: 229-235.
24. Underwood MA, Kalanetra KM, Bokulich NA et al. A comparison of two probiotic strains of bifidobacteria in premature infants. J Pediatr 2013; 163: 1585-1591.
25. Ishizeki S, Sugita M, Takata M, Yaeshima T. Effect of administration of bifidobacteria on intestinal microbiota in low-birth-weight infants and transition of administered bifidobacteria: a comparison between one-species and threespecies administration. Anaerobe 2013; 23: 38-44.
26. Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 2003; 4: 721-734.
27. Shi L, Zhang BH, Yu HG et al. Intestinal trefoil factor in treatment of neonatal necrotizing enterocolitis in the rat model. Perinat Med 2007; 35: 443-446.
28. Khailova L, Dvorak K, Arganbright KM et al. Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2009; 297: G940-G949.
29. Ewaschuk JB, Diaz H, Meddings L et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 2008; 295: G1025-G1034.
30. Zyrek AA, Cichon C, Helms S et al. Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair. Cell Microbiol 2007; 9: 804-816.
31. Liu Y, Fatheree NY, Mangalat N et al. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2010; 299: G1087-G1096.
32. Pagnini C, Saeed R, Bamias G et al. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc Natl Acad Sci U S A 2010; 107: 454-459.
33. Boirivant M, Strober W. The mechanism of action of probiotics. Curr Opin Gastroenterol 2007; 23: 679-692.
34. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241.
35. Ewaschuk JB, Blacker JL, Churchill TA et al. Surface expression of Toll-like receptor 9 is upregulated on intestinal epithelial cells in response to pathogenic bacterial DNA. Infect Immun 2007; 75: 2572-2579.
36. Veckman V, Miettinen M, Pirhonen J et al. Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of TH1-type cytokines and chemokines in human monocyte-derived dendritic cells. J Leukoc Biol 2004; 75: 764-771.
37. Salzman NH, Underwood MA, Bevins CL. Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol 2007; 19: 70-83.
38. Bevins CL, Salzman NH. Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis. Nat Rev Microbiol 2011; 9: 356-368.
39. Underwood MA, Kananurak A, Coursodon CF et al. Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses. Pediatr Res 2012; 71: 546-551.
40. Indrio F, Riezzo G, Raimondi F et al. Effect of probiotic and prebiotic on gastrointestinal motility in newborns. J Physiol Pharmacol 2009; 60: S27-S31.
41. Indrio F, Riezzo G, Raimondi F et al. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. J Pediatr 2008; 152: 801-806.
42. Robinson EL, Thompson WL. Effect on weight gain of the addition of Lactobacillus acidophilus to the formula of newborn infants. J Pediatr 1952; 41: 395-398.
43. Reuman PD, Duckworth DH, Smith KL et al. Lack of effect of lactobacillus on gastrointestinal bacterial colonisation in premature neonates. Pediatr Infect Dis 1986; 5: 663-668.
44. Kitajima H, Sumida Y, Tanaka R et al. Early administration of Bifidobacterium breve to preterm neonates: randomised control trial. Arch Dis Child 1997; 76: F101-F107.
45. Hoyos AB. Reduced incidence of necrotising enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999; 3: 197-202.
46. Dani C, Biadaioli R, Bertini G et al. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm neonates. A prospective double-blind study. Biol Neonate 2002; 82: 103-108.
47. Costalos C, Skouteri V, Gounaris A et al. Enteral feeding of premature neonates with Saccharomyces boulardii. Early Hum Dev 2003; 74: 89-96.
48. Bin-Nun A, Bromiker R, Wilschanski M et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147: 192-196.
49. Lin HC, Su BH, Chen AC et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight neonates. Pediatrics 2005; 115: 1-4.
50. Manzoni P,Mostert M, Leonessa ML et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonisation by Candida species in preterm neonates: a randomised study. Clin Infect Dis 2006; 42: 1735-1742.
51. Mohan R, Koebnick C, Schildt J et al. Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm neonates: a double placebo controlled randomised study. J Clin Microbiol 2006; 44: 4025-4031.
52. Stratiki Z, Costalos C, Sevastiadou S et al. The effect of a bifidobacteria supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev 2007; 83: 575-579.
53. Lin HC, Hsu CH, Chen HL et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008; 122: 693-700.
54. Samanta M, Sarkar M, Ghosh P et al. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 2009; 55: 128-1231.
55. Rougé C, Piloquet H, Butel MJ et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2009; 89: 1828-1835.
56. Mihatsch WA, Vossbeck S, Eikmanns B et al. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial. Neonatology 2010; 98: 156-163.
57. Braga TD, da Silva GA, de Lira PI, de Carvalho Lima M. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birthweight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr 2011; 93: 81-86.
58. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007; 369: 1614-1620.
59. Alfaleh K, Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2008; 1: CD005496.
60. Deshpande G, Rao S, Patole S, Bulsara M. Updated metaanalysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010; 125: 921-930.
61. Jacobs SE, Tobin JM, Opie GF et al. Probiotic effects on lateonset sepsis in very preterm infants: a randomized controlled trial. Pediatrics 2013; 132: 1055-1062.
62. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014; 4: CD005496.
63. Costeloe KL, Wilks M, Hardy P, Nelis C, Millar MR. Early Bifidobacterium breve BBG-001 to prevent necrotising enterocolitis, late-onset sepsis and death: The PIPS trial. Arch Dis Child 2014; 99(Suppl 2): O-008, A23.
64. Satoh Y, Shinohara K, Umezaki H et al. Bifidobacteria prevents necrotising enterocolitis and infection. Int J Probiotics Prebiotics 2007; 2: 149-154.
65. Manzoni P, Lista G, Gallo E et al. Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study. Early Hum Dev 2011; 87: S35-S38.
66. Luoto R, Isolauri E, Lehtonen L. Safety of Lactobacillus GG probiotic in infants with very low birth weight: twelve years of experience. Clin Infect Dis 2010; 50: 1327-1378.
67. Deshpande G, Shingde V, Downe L et al. Routine probiotics for preterm neonates: experience in a tertiary neonatal intensive care unit. J Pediatr Child Health 2013; 49: 50.
68. Janvier A, Malo J, Barrington KJ. Cohort study of probiotics in a North American neonatal intensive care unit. J Pediatr 2014; 164: 980-985.
69. Härtel C, Pagel J, Rupp J et al. Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants. J Pediatr 2014; 165 (2): 285-289.
70. Chou IC, Kuo HT, Chang JS et al. Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants. J Pediatr 2010; 156: 393-396.
71. Romeo MG, Romeo DM, Trovato L et al. Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol 2011; 31: 63-69.
72. Sari FN, Eras Z, Dizdar EA et al. Do oral probiotics affect growth and neurodevelopmental outcomes in very low-birth-weight preterm infants? Am J Perinatol 2012; 29: 579-586.
73. Barclay AR, Stenson B, Simpson JH et al. Probiotics for necrotizing enterocolitis: a systematic review. J Pediatr Gastroenterol Nutr 2007; 45: 569-576.
74. Mihatsch WA, Braegger CP, Decsi T et al. Critical systematic review of the level of evidence for routine use of probiotics for reduction of mortality and prevention of necrotizing enterocolitis and sepsis in preterm infants. Clin Nutr 2012; 31 (1): 6-15.
75. Mihatsch WA. What is the power of evidence recommending routine probiotics for necrotizing enterocolitis prevention in preterm infants? Curr Opin Clin Nutr Metab Care 2011; 14: 302-306.
76. Neu J. Probiotics and necrotizing enterocolitis. Clin Perinatol 2014; 41: 967-978.
77. Ganguli K, Walker WA. Probiotics in the prevention of necrotizing enterocolitis. J Clin Gastroenterol 2011; 45(Suppl): S133-S138.
78. Vandenplas Y, Veereman-Wauters G. Probiotics: fishing in the ocean. J Pediatr Gastroenterol Nutr 2012; 54(1): 4-5.
79. Obtaining the unapproved therapeutic goods as an Authorised Prescriber in Australia. [Accessed 10 June 2014.] Available from URL: http://www.tga.gov.au/hp/access-authorisedprescriber-obtain.htm.
80. Deshpande GC, Rao SC, Keil AD, Patole SK. Evidencebased guidelines for use of probiotics in preterm neonates. BMC Med 2011; 2: 92.
81. Patole S, Keil AD, Chang A et al. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates-a randomised double blind placebo controlled trial. PLoS ONE 2014; 9: e89511.
82. Drago L, Rodighiero V, Celeste T et al. Microbiological evaluation of commercial probiotic products available in the USA in 2009. J Chemother 2011; 22: 373-377.
83. Thompson C, McCarter YS, Krause PJ, Herson VC. Lactobacillus acidophilus sepsis in a neonate. J Perinatol 2001; 21: 258-260.
84. Broughton RA, Gruber WC, Haffar AA, Baker CJ. Neonatal meningitis due to lactobacillus. Pediatr Infect Dis 1983; 2: 382-384.
85. Perapoch J, Planes AM, Querol A et al. Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levure. Eur J Clin Microbiol Infect Dis 2000; 19: 468-470.
86. Ohishi A, Takahashi S, Ito Y et al. Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele. J Pediatr 2010; 156: 679-681.
87. Centers for Disease Control and Prevention. Fatal gastrointestinal mucormycosis in an infant following use of contaminated ABC dophilus powder from Solgar Inc, 2014. [Accessed 15 January 2015.] Available from URL: http://www.cdc.gov/fungal/rhizopus-investigation.html.
88. Egervärn M, Lindmark H, Olsson J, Roos S. Transferability of a tetracycline resistance gene from probiotic Lactobacillus reuteri to bacteria in the gastrointestinal tract of humans. Antonie Van Leeuwenhoek 2010; 97: 189-200.
89. Egervärn M, Roos S, Lindmark H. Identification and characterization of antibiotic resistance genes in Lactobacillus reuteri and Lactobacillus plantarum. J Appl Microbiol 2009; 107: 1658-1668.
90. Rao RK, Samak G. Protection and restitution of gut barrier by probiotics: nutritional and clinical implications. Curr Nutr Food Sci 2013; 9: 99-107.
91. Dilli D, Aydin B, Zenciroglu A et al. Treatment outcomes of infants with cyanotic congenital heart disease treated with synbiotics. Pediatrics 2013; 132: e932-e938.
92. Wang X, Li Z, Xu Z et al. Probiotics prevent Hirschsprung's disease-associated enterocolitis: a prospective multicenter randomized controlled trial. Int J Colorectal Dis 2015; 30(1): 105-110.
93. El-Sawaf M, Siddiqui S, Mahmoud M et al. Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. J Pediatr Surg 2013; 48: 111-117.
94. Reddy VS, Patole SK, Rao S. Role of probiotics in short bowel syndrome in infants and children-a systematic review. Nutrients 2013; 5: 679-699.
95. Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteremia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr 2004; 38: 457-458.
96. de Groote MA, Frank DN, Dowell E et al. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005; 24: 278-280.
97. Munakata S, Arakawa C, Kohira R et al. A case of D-lactic acid encephalopathy associated with use of probiotics. Brain Dev 2010; 32: 691-694.
98. Ku WH, Lau DC, Huen KF. Probiotics provoked D-lactic acidosis in short bowel syndrome: case report and literature review. Hong Kong J Paediatr 2006; 11: 246-254.